Pediatrix Medical
198 hedge funds and large institutions have $1.82B invested in Pediatrix Medical in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 101 increasing their positions, 55 reducing their positions, and 36 closing their positions.
84% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 55
2.19% more ownership
Funds ownership: 96.93% → 99.13% (+2.2%)
8% less capital invested
Capital invested by funds: $1.98B → $1.82B (-$167M)
12% less funds holding
Funds holding: 224 → 198 (-26)
58% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 36
88% less call options, than puts
Call options by funds: $668K | Put options by funds: $5.74M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$22M |
| 2 |
BlackRock
New York
|
+$17.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.5M |
| 4 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
+$7.85M |
| 5 |
EARNEST Partners
Atlanta,
Georgia
|
+$7.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$43.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.65M |
| 3 |
Renaissance Technologies
New York
|
-$3.79M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.38M |
| 5 |
EGM
Engineers Gate Manager
New York
|
-$1.94M |
MD Hedge Fund Activity: Q2 2022 in Review
198 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2022, worth a combined $1.82B — down 8.4% from $1.98B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of MD and 15 opened new positions — a net loss of 21 holders — while 55 trimmed existing stakes and 101 added.
The largest buyer was Lazard Asset Management, adding an estimated $22M. The largest seller was Wellington Management Group, exiting entirely with an estimated $43.6M sold.
- 198 institutional investors held Pediatrix Medical (MD) as of Q2 2022, down from 224 in Q1 2022.
- Funds reported $1.82B of Pediatrix Medical stock for Q2 2022, down 8.4% quarter-over-quarter.
- 15 funds opened new Pediatrix Medical positions in Q2 2022 and 36 closed out, a net change of -21 holders.
- The largest Pediatrix Medical buyer in Q2 2022 was Lazard Asset Management, an estimated $22M added.
- The largest Pediatrix Medical seller in Q2 2022 was Wellington Management Group, an estimated $43.6M sold.
Based on aggregated 13F filings for Q2 2022.